[HTML][HTML] Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck

FX Hanin, N Cappoen, JP Machiels - Annals of oncology, 2013 - Elsevier
Background To investigate the safety and activity of cetuximab in the pre-operative treatment
of squamous cell carcinoma of the head and neck (SCCHN). Patients and methods …

[引用][C] Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck

S SCHMITZ, M HAMOIR, M LONNEUX… - Annals of …, 2013 - pascal-francis.inist.fr
Tumour response and safety of cetuximab in a window pre-operative study in patients with
squamous cell carcinoma of the head and neck CNRS Inist Pascal-Francis CNRS Pascal …

[PDF][PDF] Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck

S Schmitz, M Hamoir, H Reychler, M Magremanne… - 2013 - researchgate.net
Background: To investigate the safety and activity of cetuximab in the pre-operative
treatment of squamous cell carcinoma of the head and neck (SCCHN). Patients and …

[引用][C] Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck.

S Schmitz, M Hamoir, H Reychler… - Annals of …, 2013 - dial.uclouvain.be
Short-course pre-operative administration of cetuximab is safe and shows a high rate of (18)
FDG-PET response.(18) FDG-PET response was correlated with residual tumour cellularity …

[PDF][PDF] Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck

S Schmitz, M Hamoir, H Reychler, M Magremanne… - 2013 - academia.edu
Background: To investigate the safety and activity of cetuximab in the pre-operative
treatment of squamous cell carcinoma of the head and neck (SCCHN). Patients and …

Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck

S Schmitz, M Hamoir, H Reychler… - Annals of …, 2013 - annalsofoncology.org
Background To investigate the safety and activity of cetuximab in the pre-operative treatment
of squamous cell carcinoma of the head and neck (SCCHN). Patients and methods …

Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck.

S Schmitz, M Hamoir, H Reychler… - Annals of Oncology …, 2013 - europepmc.org
Tumour response and safety of cetuximab in a window pre-operative study in patients with
squamous cell carcinoma of the head and neck. - Abstract - Europe PMC Sign in | Create an …

Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck

S Schmitz, M Hamoir, H Reychler… - Annals of oncology …, 2013 - pubmed.ncbi.nlm.nih.gov
Background To investigate the safety and activity of cetuximab in the pre-operative treatment
of squamous cell carcinoma of the head and neck (SCCHN). Patients and methods …

[PDF][PDF] Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck

S Schmitz, M Hamoir, H Reychler, M Magremanne… - 2013 - academia.edu
Background: To investigate the safety and activity of cetuximab in the pre-operative
treatment of squamous cell carcinoma of the head and neck (SCCHN). Patients and …

[引用][C] Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck

S Schmitz, M Hamoir, H Reychler… - Annals of …, 2013 - Oxford University Press